Authors:
BARKSDALE CM
NORDBLOM GD
DUDECK RC
WELTY DF
JORDAN S
BIGGE CF
YI CS
Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID, Journal of clinical ligand assay, 21(3), 1998, pp. 324-330
Citation: Xl. Liang et al., ON PROBE IMMUNOAFFINITY EXTRACTION BY MATRIX-ASSISTED-LASER-DESORPTION IONIZATION MASS-SPECTROMETRY/, Analytical chemistry, 70(3), 1998, pp. 498-503
Authors:
BARKSDALE CM
BURGER PJ
NORDBLOM GD
COOK JA
KIRKISH LS
MICHNIEWICZ BM
DUDECK RC
HODGES JC
KLUTCHKO SR
CONNOLLY CJC
Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR THE ORALLY-ACTIVE RENIN INHIBITOR CI-992 IN CYNOMOLGUS MONKEY AND HUMAN PLASMA, Journal of clinical ligand assay, 20(3), 1997, pp. 251-257
Authors:
BARKSDALE CM
COON MJ
TURLUCK DA
GUTTENDORF RJ
NORDBLOM GD
Citation: Cm. Barksdale et al., PHARMACOKINETICS AND BIOAVAILABILITY OF CI-977 IN RATS AND DOGS, Journal of clinical ligand assay, 20(2), 1997, pp. 206-211
Authors:
BARKSDALE CM
NORDBLOM GD
MILJANICH GP
TARCZYHORNOCH K
KRISTIPATI R
KUGLER AR
Citation: Cm. Barksdale et al., DEVELOPMENT OF A RADIOIMMUNOASSAY FOR THE NOVEL N-TYPE CALCIUM-CHANNEL BLOCKER, SNX-111 (CI-1009), Journal of clinical ligand assay, 19(4), 1996, pp. 229-233
Authors:
SIZEMORE N
DUDECK RC
BARKSDALE CM
NORDBLOM GD
MUELLER WT
MCCONNELL P
WRIGHT DS
GUGLIETTA A
KUO BS
Citation: N. Sizemore et al., DEVELOPMENT AND VALIDATION OF 2 SOLID-PHASE ENZYME IMMUNOASSAYS (ELISA) FOR QUANTITATION OF HUMAN EPIDERMAL GROWTH-FACTORS (HEGFS), Pharmaceutical research, 13(7), 1996, pp. 1088-1094
Authors:
KAGEL JR
ROSSI DT
NORDBLOM GD
DUDECK RC
BARKSDALE CM
KUO BS
WRIGHT DS
Citation: Jr. Kagel et al., CONSIDERATIONS IN THE DEVELOPMENT OF A SENSITIVE HPLC ASSAY FOR HUMANEPIDERMAL GROWTH-FACTORS IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 13(10), 1995, pp. 1205-1213